{
    "clinical_study": {
        "@rank": "5035", 
        "arm_group": [
            {
                "arm_group_label": "Surgical Gastric Bypass", 
                "arm_group_type": "Experimental", 
                "description": "Patients will undergo surgical gastric bypass according to standard institutional protocols"
            }, 
            {
                "arm_group_label": "Medical Weight Loss Management", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive best practices medical management for weight loss under current institutional protocols"
            }
        ], 
        "brief_summary": {
            "textblock": "Gastric Bypass followed by renal transplantation is superior to medical management followed\n      by renal transplant for patients with severe obesity and renal failure."
        }, 
        "brief_title": "Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure", 
        "condition": [
            "Severe Obesity", 
            "Renal Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity, Morbid", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Body mass index 40-55 kg/m2\n\n          -  Age less than 55 years\n\n          -  Available support person\n\n          -  Adequate insurance\n\n          -  All other criteria required for renal transplantation\n\n        Exclusion Criteria:\n\n          -  Schizophrenia\n\n          -  Bipolar disorder\n\n          -  Crohn's disease\n\n          -  Human Immunodeficiency Virus\n\n          -  Cirrhosis\n\n          -  Prior weight loss surgery\n\n          -  Prior mesh hernia repair\n\n          -  Prior anti-reflux surgery\n\n          -  Inability to walk 200 feet\n\n          -  Significant coronary disease\n\n          -  Significant lung disease - Fixed expiratory volume 1 less than 75% or on oxygen\n\n          -  Addiction to alcohol or drugs\n\n          -  Inability to quit smoking\n\n          -  Jehovah's witness\n\n          -  Non-compliance with dialysis regimen\n\n          -  Previous renal transplant\n\n          -  Non-English speaking"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02128802", 
            "org_study_id": "130912"
        }, 
        "intervention": [
            {
                "arm_group_label": "Surgical Gastric Bypass", 
                "intervention_name": "Gastric Bypass", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Medical Weight Loss Management", 
                "intervention_name": "Weight Loss Program", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obesity", 
            "Renal failure", 
            "Gastric bypass"
        ], 
        "lastchanged_date": "April 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Nashville", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37232"
                }, 
                "name": "Vanderbilt University Medical Center"
            }, 
            "investigator": {
                "last_name": "Seth Karp, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Weight Reduction Surgery Followed by Kidney Transplantation for Patients With Class III Obesity and Renal Failure", 
        "other_outcome": {
            "description": "This outcome will assess the amount of prograf required for therapeutic levels", 
            "measure": "Prograf dosing", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "overall_contact": {
            "email": "seth.karp@vanderbilt.edu", 
            "last_name": "Seth Karp, MD", 
            "phone": "6159368989"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Outcomes will be measured based on weight loss and a variety of validated surveys and questionnaires to measure HRQOL", 
            "measure": "Ability to reach medical suitability for renal transplant within 18 months after initiating treatment and the change and trajectory of health-related quality of life (HRQOL)", 
            "safety_issue": "Yes", 
            "time_frame": "18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02128802"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Vanderbilt University", 
            "investigator_full_name": "Seth Karp", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of patients who die from any cause", 
                "measure": "All-cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Amount of weight lost at various points over the study period", 
                "measure": "Weight loss", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Incidence of surgical complications including but not limited to leak rate, stricture rate, pulmonary embolism, and infection.", 
                "measure": "Surgical outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Including but not limited to start of stop of insulin therapy, amount of insulin required, and start or stop of or cal medications.", 
                "measure": "Development or regression of diabetes", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Development or regression of other diseases including but not limited to hypertension, coronary artery disease, and skin infections.", 
                "measure": "Development or regression of other comorbidities", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "description": "This outcome measure includes but is not limited to the amount of money spent on health care, total hospitalization, days of hospitalization, and procedures required.", 
                "measure": "Health care utilization", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "This outcome includes but is not limited to measures of albumin, pre-albumin, and caloric intake.", 
                "measure": "Nutritional status", 
                "safety_issue": "Yes", 
                "time_frame": "5 years"
            }, 
            {
                "description": "This outcome includes but is not limited to measurement of protein catabolism, creatinine clearance, and serum prealbumin.  In addition, protein and iron metabolism will be measured using serum albumin, transferrin and ferritin.  Glucose metabolism will be measured by glucose and insulin levels.  regression of the disease.  Lipid metabolism will be assessed with triglyceride levels, very-low density lipoproteins, and cholesterol.  Micronutrient levels will be measured with vitamin D, thiamin, B12, and folate.", 
                "measure": "Hormonal and metabolic status", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Vanderbilt University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vanderbilt University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}